TradeStation Europe Expands Options Capability, Including Extended-Hours Trading
29.10.2026 11:43:00 CET | Business Wire | Press release
Expanded intraday and options trading capability, combined with lower options and equities commissions across the Netherlands and the EEA
TradeStation Europe B.V. (“TradeStation Europe”), the recently licensed European brokerage subsidiary of TradeStation Group, Inc. (“TradeStation”), today announced a round of product updates, including extended-hours options trading, along with reduced options and equities pricing, new single-stock option spreads and expanded intraday trading to enhance the offering for retail and institutional traders across the Netherlands and the European Economic Area (EEA).
Extended-hours options trading is now live. Clients can trade eligible equity options during a pre-market session from 7:30 a.m. to 9:25 a.m. ET and an extended curb session from 4:00 p.m. to 4:15 p.m. ET.
The launch follows Cboe Global Markets, Inc.’s (Cboe: CBOE) introduction of extended trading hours for options on 24 individual stocks and five ETFs, expanding access to some of the most actively traded and liquid single-stock options outside of the regular U.S. trading session.
The enhancement expands access beyond traditional market hours, giving active traders more freedom to respond to pre-market earnings announcements, economic data releases, overnight geopolitical developments, and other events that may influence market sentiment before and after the regular trading session. The additional trading windows also provide clients with more opportunities to manage risk, hedge positions, and adjust their strategies as market conditions evolve.
The update also includes:
- Single-stock option spreads – clients in Europe can now build multi-leg option spread strategies on individual equities, in addition to existing single-leg options access
- Expanded intraday access – active traders have wider intraday trading capabilities across equities, options and futures, alongside reduced intraday futures margin* requirements
- Reduced options commissions† – options are now priced at $0.60 per contract
- Reduced equities commissions – equities pricing is now $0.005 per share
“These updates extend a run of product enhancements since TradeStation Europe began operating in June 2026 as a fully licensed MiFID investment firm regulated by the Dutch Authority for the Financial Markets (AFM),” said Peter Comstock, President of TradeStation Europe. “We moved quickly to bring extended-hours options trading to clients once Cboe made it available. Traders in Europe deserve the most comprehensive access to U.S. markets and our clients now have more flexibility to respond, manage risk and trade earlier in their day. This continues TradeStation Europe’s mission of being the ideal gateway to U.S. listed markets for European institutions and sophisticated traders.”
TradeStation Europe provides access to U.S. equities, options, futures and futures options markets backed by local support, compliance and multilingual teams. For more information on TradeStation Europe and how to open an account, visit tradestation.eu.
*Futures trading is not suitable for all investors. See the futures risk disclosures included in the Futures Customer Agreement on TradeStation.eu/important-information/. Margin trading involves risks, and it is important that you fully understand those risks before trading on margin. The Margin Disclosure Statement outlines many of those risks, including that you can lose more funds than you deposit in your margin account; your brokerage firm can force the sale of securities in your account; your brokerage firm can sell your securities without contacting you; and you are not entitled to an extension of time on a margin call. Review the Margin Disclosure Statement at TradeStation.eu/MarginDisclosure/.
†Options trading is not suitable for all investors. Your TradeStation Europe Securities' account application to trade options will be considered and approved or disapproved based on all relevant factors, including your trading experience. See the options risk disclosures included in the Equities Customer Agreement on TradeStation.eu/important-information/. Fees and charges may apply. Visit TradeStation.eu/Pricing for full details on the costs and fees associated with options and equities trading.
Past performance, whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. There is a possibility that you may sustain a loss equal to or greater than your entire investment regardless of which asset class you trade (equities, options or futures); therefore, you should not invest or risk money that you cannot afford to lose. Online trading is not suitable for all investors. Before trading any asset class, customers must read the relevant risk disclosure statements included in the Customer Agreements on TradeStation.eu/important-information/. System access and trade placement and execution may be delayed or fail due to market volatility and volume, quote delays, system and software errors, Internet traffic, outages and other factors.
About TradeStation Group, Inc.
Founded in 1982, TradeStation Group companies provide institutional-grade fintech tools and account-related services – and are where traders can find their home. TradeStation Group, Inc. is the parent company of several subsidiaries, including TradeStation Securities, Inc., TradeStation Europe B.V., and TradeStation Technologies, Inc. TradeStation Group companies seek to deliver the ultimate trading experience to retail and institutional clients that need a customizable trading ecosystem to perform their strategies. TradeStation Technologies provides award-winning‡ trading and analysis platforms through its affiliates TradeStation Securities, Inc. and TradeStation Europe B.V., which provide online brokerage services for equities, options, futures, and futures options. These advanced trading tools are accessible on desktop, web, and mobile devices, as well as via API technologies that provide seamless access to their brokerage services through third-party platforms. Created by traders, for traders, TradeStation Group companies’ institutional-level offerings cater to those who are born to trade. Learn more about TradeStation Group companies.
‡Visit TradeStation.eu/awards/ to learn more.
About TradeStation Europe B.V.
TradeStation Europe B.V. (TradeStation Europe) is the European brokerage arm of TradeStation Group, Inc. From its headquarters in Amsterdam, Netherlands, TradeStation Europe services institutional and retail clients in the European Economic Area, offering direct connectivity to U.S. markets. TradeStation Europe is a licensed MiFID Investment Firm registered with the Dutch Chamber of Commerce (no. 89426657) and regulated by the Dutch Authority for the Financial Markets in the Netherlands, with execution, clearing, and custody arrangements through TradeStation Securities, Inc. (Member NYSE, FINRA, SIPC, NSCC, DTC, OCC, NFA & CME), which is registered as a broker-dealer with the U.S. Securities and Exchange Commission, a futures commission merchant with the U.S. Commodity Futures Trading Commission, and a member of major equities and futures exchanges in the United States. Created by traders, for traders, TradeStation delivers institutional-grade tools and concierge services designed for those who are Born to Trade. Learn more about TradeStation Europe.
View source version on businesswire.com: https://www.businesswire.com/news/home/20261028548763/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Two Single-Pill Triple Combination Lipid-Lowering Therapy Applications Validated in The European Union29.10.2026 12:27:00 CET | Press release
EMA has validated two marketing authorization applications from Daiichi Sankyo in the EU for single-pill triple-combinations of established lipid-lowering agents: bempedoic acid, ezetimibe, and either atorvastatin or rosuvastatin If approved, the proposed therapies could be the first oral single-pill triple-combinations for lipid-lowering in the EU, aiming to simplify treatment for patients requiring multiple lipid-lowering agents The submissions reflect the commitment of Daiichi Sankyo to addressing unmet needs in cardiovascular disease The European Medicines Agency (EMA) has validated two marketing authorization applications (MAA) from Daiichi Sankyo (TSE: 4568) for oral, single-pill triple-combination therapies. The applications seek approval for the treatment of adults with primary hypercholesterolemia or mixed dyslipidemia to reduce low-density lipoprotein cholesterol (LDL-C) levels and cardiovascular (CV) risk. Despite the availability of effective therapies, treatment discontinu
NIQ and Google Partner to Advance Agentic Commerce29.10.2026 11:45:00 CET | Press release
Built with Google Cloud and Gemini for business, NIQ and Google commit to transforming AI-driven product discovery, availability, and measurement Today, NielsenIQ (NYSE: NIQ) and Google announced a broad collaboration to advance agentic commerce, aiming to bring NIQ’s global retail and product intelligence together with Google’s AI commerce ecosystem to improve product discovery and local availability. NIQ and Google are looking to complement Google's extensive Shopping Graph of more than 60 billion product listings with NIQ’s Commerce Intelligence. NIQ is also naming Google Cloud as a primary AI and cloud services provider, and plans to deploy Gemini for business across its global workforce. As AI evolves from helping consumers discover products to recommending and purchasing them, brands and retailers increasingly rely on trusted product information, real-world availability, and measurement. The partnership is designed to help make agentic commerce even more reliable and measurable,
Chiesi Group appoints Paolo Paoletti to its Board of Directors29.10.2026 11:01:00 CET | Press release
HIGHLIGHTS:Paolo Paoletti, M.D., joins Chiesi's Board of Directors as its fourth independent member, effective as of today.An internationally recognized pharmaceutical leader, he brings more than 30 years of experience spanning R&D, biotechnology innovation and global healthcare leadership.His appointment further strengthens the Board's scientific and strategic expertise as Chiesi advances its commitment to delivering innovative solutions for patients. Chiesi, the international research-focused biopharmaceutical group, today announced the appointment of Paolo Paoletti, M.D. to its Board of Directors, effective as of today. Paoletti is an internationally recognized pharmaceutical executive with more than 30 years of experience across research and development, corporate leadership and biotechnology innovation. Throughout his career, he has held senior leadership positions at Lilly, GlaxoSmithKline (GSK) and GammaDelta Therapeutics, contributing to the development and commercialization of
Icon Solutions Appoints Raquel Guillot as Southern Europe Sales Director to Drive Global Adoption of the Icon Payments Framework29.10.2026 10:30:00 CET | Press release
Madrid-based appointment will focus on expanding the company’s presence across Southern Europe and developing opportunities in new markets Icon Solutions – the UK fintech enabling banks globally to design and implement state-of-the-art payment systems – has appointed Raquel Guillot as Southern Europe Sales Director, to drive adoption of the Icon Payments Framework (IPF) across the region. Guillot brings around 20 years of experience spanning banking, analytics, fraud prevention, payments and core banking technology. She began her career at Citibank before moving into financial technology, holding roles at SAS, ACI Worldwide and other technology providers, including Thought Machine. IPF is the internationally proven payments development framework trusted by banks across the globe, including Citi, UBS, NatWest and BNP Paribas. It enables banks to transform their systems in an accelerated, structured and low-risk way, all on their own terms. Based in Madrid, Guillot will focus on expandin
Alushibe Holding Group to Bring 12 Global F&B Brands to Libya by 202829.10.2026 09:00:00 CET | Press release
Ahmed Gadalla signs exclusive master franchise agreement with Türkiye's MADO: US$7 million, 7 cafés and 350 jobs in the first phase; 1,000 sq m Benghazi flagship opens Q1 2027 Alushibe Holding Group today announced plans to bring 12 international food-and-beverage brands to Libya by 2028 through its Retail & Destinations division, beginning with an exclusive master franchise agreement with MADO, the Turkish ice-cream and patisserie house founded in 1850. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261029822317/en/ Ahmed Gadalla signs exclusive master franchise agreement with Türkiye's MADO: US$7 million, 7 cafés and 350 jobs in the first phase; 1,000 sq m Benghazi flagship opens Q1 2027 – (Photo: AETOSWire) Signed in Kahramanmaraş on 13 October 2026 by Ahmed Gadalla, Founder and Chairman of Alushibe Holding Group, and Mehmet Sait Kanbur, Chairman of MADO, the agreement grants Alushibe exclusive rights to develop and opera
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom